
X
Gilead and Novo plot next steps after trial data from NASH combo
https://pharmaphorum.com/news/gilead-and-novo-plot-next-steps-after-encouraging-data-from-nash-combo/
Novo hopes for blockbuster sales from semaglutide
Danish pharma plans outcome trial to confirm benefits in SUSTAIN 6